E. de Jong

发表

Markers for proliferation and keratinization in the margin of the active psoriatic lesion.

P. V. D. van de Kerkhof, P. V. van Erp, S. de Mare, 1990, The British journal of dermatology.

Period of remission after treatment with UVA‐1 in sclerodermic skin diseases

E. D. De Jong, P. V. D. van de Kerkhof, M. Gerritsen, 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept

P. V. D. van de Kerkhof, P. Spuls, J. Boezeman, 2010, The British journal of dermatology.

Paediatric‐onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA‐C*06

M. den Heijer, E. D. De Jong, J. Schalkwijk, 2012, The British journal of dermatology.

CD26/dipeptidyl‐peptidase IV in psoriatic skin: upregulation and topographical changes

P. van Erp, P. V. D. van de Kerkhof, E. D. De Jong, 2008, The British journal of dermatology.

Löffler syndrome caused by extensive cutaneous larva migrans: a case report and review of the literature.

H. Bovenschen, E. de Jong, M. te Booij, 2010, Dermatology online journal.

Juvenile psoriasis in European and Asian children: similarities and differences

E. D. De Jong, P. V. D. van de Kerkhof, M. Seyger, 2011, The British journal of dermatology.

Update of advanced cutaneous squamous cell carcinoma

J. Bouwes Bavinck, R. Genders, E. de Jong, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Increased incidence of squamous cell carcinoma of the skin after long‐term treatment with azathioprine in patients with auto‐immune inflammatory rheumatic diseases

J. Hendriks, E. D. De Jong, P. V. D. van de Kerkhof, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Safety of treatment with biologics for psoriasis in daily practice: 5‐year data

P. V. D. van de Kerkhof, J. Boezeman, M. Berends, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

No evidence found that childhood onset of psoriasis influences disease severity, future body mass index or type of treatments used

E. D. De Jong, P. V. D. van de Kerkhof, M. Seyger, 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology‐specific health instrument

F. Kraaimaat, A. Evers, P. V. D. van de Kerkhof, 2007, The British journal of dermatology.

Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab

E. D. De Jong, P. V. D. van de Kerkhof, P. V. van Lümig, 2011, The British journal of dermatology.

Individual differences in the effect of daily stressors on psoriasis: a prospective study

F. Kraaimaat, E. Verhoeven, E. D. De Jong, 2009, The British journal of dermatology.

A pilot study on the Psoriasis Area and Severity Index (PASI) for small areas: Presentation and implications of the Low PASI score

J. Hendriks, P. V. D. van de Kerkhof, M. Seyger, 2015, The Journal of dermatological treatment.

How stress gets under the skin: cortisol and stress reactivity in psoriasis

F. Kraaimaat, F. Sweep, E. Verhoeven, 2010, The British journal of dermatology.

Topical treatment of mild to moderate plaque psoriasis with 0·3% tacrolimus gel and 0·5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T‐cell subsets and HLA‐DR expression

P. V. D. van de Kerkhof, P. V. van Erp, I. V. van Vlijmen, 2008, The British journal of dermatology.

Three‐year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome

P. V. D. van de Kerkhof, J. Boezeman, E. de Jong, 2009, The British journal of dermatology.

The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T‐cell subsets in chronic plaque psoriasis

P. van Erp, E. D. De Jong, P. V. D. van de Kerkhof, 2004, Experimental dermatology.

The effect of alefacept on T‐cell subsets and cells expressing NK receptors in lesional psoriatic skin: The effects of monotherapy and combination treatment with calcipotriol

P. van Erp, E. D. De Jong, P. V. D. van de Kerkhof, 2008, The Journal of dermatological treatment.

Safety of treatment with biologics for psoriasis in daily practice: 5-year data

P. V. D. van de Kerkhof, J. Boezeman, M. Berends, 2010, Journal of Translational Medicine.

Relevance of compartmentalization of T‐cell subsets for clinical improvement in psoriasis: effect of immune‐targeted antipsoriatic therapies

A. Langewouters, E. D. De Jong, P. V. D. van de Kerkhof, 2008, The British journal of dermatology.

Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry

E. Hoppenreijs, J. Hendriks, E. D. De Jong, 2015, The Journal of dermatological treatment.

Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin.

A. Hoitsma, E. D. De Jong, P. V. D. van de Kerkhof, 2003, Journal of the American Academy of Dermatology.